Ontology type: schema:ScholarlyArticle
2005-07-11
AUTHORSCarla Oliveira, Sérgia Velho, Enric Domingo, Ana Preto, Robert M W Hofstra, Richard Hamelin, Hiroyuki Yamamoto, Raquel Seruca, Simo Schwartz
ABSTRACTMethylation-associated inactivation of RASSF1A has frequently been observed in several human malignancies including sporadic colorectal and gastric cancer. However, nothing is known about the RASSF1A methylation status in the setting of MMR-deficient gastrointestinal tumours. In this study, we analysed systematically alterations in KRAS, BRAF and RASSF1A, in order to define the frequency and the pattern of these genetic/epigenetic alterations in three distinct subsets of MSI gastrointestinal tumours. Further, an association study was performed between RASSF1A methylation and the clinicopathological parameters in order to determine the profile of tumours harbouring this epigenetic event. A total of 56 MSI sporadic gastrointestinal tumours (31 colorectal and 25 gastric) and 20 MSI HNPCC analysed for KRAS/BRAF were analysed for RASSF1A promoter hypermethylation by MSP and DNA sequencing. No significant differences were found between the frequency of RASSF1A methylation in sporadic MSI colorectal and gastric carcinomas and HNPCC carcinomas (P=0.31). Methylation of RASSF1A was present in 16 of 31 (52%) sporadic MSI colorectal and 11 of 25 (44%) MSI gastric carcinomas, and in six of 20 (30%) HNPCC carcinomas. Nearly 36% of MSI sporadic colorectal carcinomas (CRCs) had RASSF1A methylation and activating mutations at KRAS and/or BRAF. In contrast, only 10 and 8% of HNPCC and sporadic gastric carcinomas, respectively, had concomitant KRAS mutations and RASSF1A methylation. The MSI sporadic gastric and CRCs with RASSF1A methylation were preferentially poorly differentiated (P=0.03, 0.05, respectively). We show that the profile of alterations RASSF1A, KRAS/BRAF is different among the three groups of MSI gastrointestinal tumours. Further, we demonstrate that MSI sporadic CRCs accumulated significantly more epigenetic/genetic alterations in RASSF1A, KRAS/BRAF than MSI sporadic gastric or HNPCC carcinomas (P=0.016). These results are likely to have therapeutic implications in the near future, due to the possibilities of using specific kinase inhibitors alone or in association with demethylating agents in MSI tumour types harbouring KRAS or BRAF mutations and RASSF1A methylation. More... »
PAGES7630-7634
http://scigraph.springernature.com/pub.10.1038/sj.onc.1208906
DOIhttp://dx.doi.org/10.1038/sj.onc.1208906
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1001626065
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/16007118
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Carcinoma",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Colorectal Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "DNA Methylation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "DNA Mutational Analysis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Genes, ras",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Genetic Predisposition to Disease",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Microsatellite Repeats",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Mutation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Promoter Regions, Genetic",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Proto-Oncogene Proteins B-raf",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Stomach Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Tumor Suppressor Proteins",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Rua Roberto Frias S/N, 4200-465, Porto, Portugal",
"id": "http://www.grid.ac/institutes/grid.5808.5",
"name": [
"Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Rua Roberto Frias S/N, 4200-465, Porto, Portugal"
],
"type": "Organization"
},
"familyName": "Oliveira",
"givenName": "Carla",
"id": "sg:person.011232615740.23",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011232615740.23"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Rua Roberto Frias S/N, 4200-465, Porto, Portugal",
"id": "http://www.grid.ac/institutes/grid.5808.5",
"name": [
"Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Rua Roberto Frias S/N, 4200-465, Porto, Portugal"
],
"type": "Organization"
},
"familyName": "Velho",
"givenName": "S\u00e9rgia",
"id": "sg:person.0651454231.02",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651454231.02"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Molecular Oncology and Aging Research. Centre d'Investigacions en Bioquimica i Biologia Molecular (CIBBIM), Hospital Universitari Vall d'Hebron, 08035, Barcelona, Spain",
"id": "http://www.grid.ac/institutes/grid.411083.f",
"name": [
"Molecular Oncology and Aging Research. Centre d'Investigacions en Bioquimica i Biologia Molecular (CIBBIM), Hospital Universitari Vall d'Hebron, 08035, Barcelona, Spain"
],
"type": "Organization"
},
"familyName": "Domingo",
"givenName": "Enric",
"id": "sg:person.0753633043.29",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753633043.29"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Rua Roberto Frias S/N, 4200-465, Porto, Portugal",
"id": "http://www.grid.ac/institutes/grid.5808.5",
"name": [
"Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Rua Roberto Frias S/N, 4200-465, Porto, Portugal"
],
"type": "Organization"
},
"familyName": "Preto",
"givenName": "Ana",
"id": "sg:person.01040613252.51",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040613252.51"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Medical Genetics, University of Groningen, A Deusinglaan 4, 9713 AW, Groningen, The Netherlands",
"id": "http://www.grid.ac/institutes/grid.4830.f",
"name": [
"Department of Medical Genetics, University of Groningen, A Deusinglaan 4, 9713 AW, Groningen, The Netherlands"
],
"type": "Organization"
},
"familyName": "Hofstra",
"givenName": "Robert M W",
"id": "sg:person.014021511117.04",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014021511117.04"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "INSERM U434 CEPH, 75010, Paris, France",
"id": "http://www.grid.ac/institutes/grid.7429.8",
"name": [
"INSERM U434 CEPH, 75010, Paris, France"
],
"type": "Organization"
},
"familyName": "Hamelin",
"givenName": "Richard",
"id": "sg:person.0611313613.55",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611313613.55"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "First Department of Internal Medicine, Sapporo Medical University, 060-8543, Sapporo, Japan",
"id": "http://www.grid.ac/institutes/grid.263171.0",
"name": [
"First Department of Internal Medicine, Sapporo Medical University, 060-8543, Sapporo, Japan"
],
"type": "Organization"
},
"familyName": "Yamamoto",
"givenName": "Hiroyuki",
"id": "sg:person.0635431612.98",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635431612.98"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Faculty of Medicine, University of Porto, 4200-465, Porto, Portugal",
"id": "http://www.grid.ac/institutes/grid.5808.5",
"name": [
"Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Rua Roberto Frias S/N, 4200-465, Porto, Portugal",
"Faculty of Medicine, University of Porto, 4200-465, Porto, Portugal"
],
"type": "Organization"
},
"familyName": "Seruca",
"givenName": "Raquel",
"id": "sg:person.01277361713.77",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277361713.77"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Molecular Oncology and Aging Research. Centre d'Investigacions en Bioquimica i Biologia Molecular (CIBBIM), Hospital Universitari Vall d'Hebron, 08035, Barcelona, Spain",
"id": "http://www.grid.ac/institutes/grid.411083.f",
"name": [
"Molecular Oncology and Aging Research. Centre d'Investigacions en Bioquimica i Biologia Molecular (CIBBIM), Hospital Universitari Vall d'Hebron, 08035, Barcelona, Spain"
],
"type": "Organization"
},
"familyName": "Schwartz",
"givenName": "Simo",
"id": "sg:person.01000566750.30",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01000566750.30"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1038/418934a",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1042017236",
"https://doi.org/10.1038/418934a"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.onc.1207061",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1030493697",
"https://doi.org/10.1038/sj.onc.1207061"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nrc1278",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050255464",
"https://doi.org/10.1038/nrc1278"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.onc.1205192",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1049566475",
"https://doi.org/10.1038/sj.onc.1205192"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.onc.1205466",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022021396",
"https://doi.org/10.1038/sj.onc.1205466"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/77083",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1036186944",
"https://doi.org/10.1038/77083"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1023/b:fame.0000039861.30651.c8",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1002166811",
"https://doi.org/10.1023/b:fame.0000039861.30651.c8"
],
"type": "CreativeWork"
}
],
"datePublished": "2005-07-11",
"datePublishedReg": "2005-07-11",
"description": "Methylation-associated inactivation of RASSF1A has frequently been observed in several human malignancies including sporadic colorectal and gastric cancer. However, nothing is known about the RASSF1A methylation status in the setting of MMR-deficient gastrointestinal tumours. In this study, we analysed systematically alterations in KRAS, BRAF and RASSF1A, in order to define the frequency and the pattern of these genetic/epigenetic alterations in three distinct subsets of MSI gastrointestinal tumours. Further, an association study was performed between RASSF1A methylation and the clinicopathological parameters in order to determine the profile of tumours harbouring this epigenetic event. A total of 56 MSI sporadic gastrointestinal tumours (31 colorectal and 25 gastric) and 20 MSI HNPCC analysed for KRAS/BRAF were analysed for RASSF1A promoter hypermethylation by MSP and DNA sequencing. No significant differences were found between the frequency of RASSF1A methylation in sporadic MSI colorectal and gastric carcinomas and HNPCC carcinomas (P=0.31). Methylation of RASSF1A was present in 16 of 31 (52%) sporadic MSI colorectal and 11 of 25 (44%) MSI gastric carcinomas, and in six of 20 (30%) HNPCC carcinomas. Nearly 36% of MSI sporadic colorectal carcinomas (CRCs) had RASSF1A methylation and activating mutations at KRAS and/or BRAF. In contrast, only 10 and 8% of HNPCC and sporadic gastric carcinomas, respectively, had concomitant KRAS mutations and RASSF1A methylation. The MSI sporadic gastric and CRCs with RASSF1A methylation were preferentially poorly differentiated (P=0.03, 0.05, respectively). We show that the profile of alterations RASSF1A, KRAS/BRAF is different among the three groups of MSI gastrointestinal tumours. Further, we demonstrate that MSI sporadic CRCs accumulated significantly more epigenetic/genetic alterations in RASSF1A, KRAS/BRAF than MSI sporadic gastric or HNPCC carcinomas (P=0.016). These results are likely to have therapeutic implications in the near future, due to the possibilities of using specific kinase inhibitors alone or in association with demethylating agents in MSI tumour types harbouring KRAS or BRAF mutations and RASSF1A methylation.",
"genre": "article",
"id": "sg:pub.10.1038/sj.onc.1208906",
"isAccessibleForFree": false,
"isFundedItemOf": [
{
"id": "sg:grant.3533751",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.3532475",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1097543",
"issn": [
"0950-9232",
"1476-5594"
],
"name": "Oncogene",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "51",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "24"
}
],
"keywords": [
"KRAS/BRAF",
"gastrointestinal tumors",
"HNPCC carcinomas",
"colorectal carcinoma",
"RASSF1A methylation",
"sporadic colorectal carcinomas",
"gastric carcinoma",
"sporadic gastric",
"BRAF mutations",
"KRAS/BRAF mutations",
"concomitant KRAS mutation",
"sporadic colorectal cancer",
"RASSF1A methylation status",
"profiles of tumors",
"RASSF1A promoter hypermethylation",
"colorectal cancer",
"clinicopathological parameters",
"gastric cancer",
"KRAS mutations",
"sporadic colorectal",
"therapeutic implications",
"carcinoma",
"methylation of RASSF1A",
"sporadic gastric carcinomas",
"tumor types",
"RASSF1A hypermethylation",
"methylation-associated inactivation",
"tumors",
"human malignancies",
"colorectal",
"BRAF",
"kinase inhibitors",
"distinct subsets",
"KRAS",
"specific kinase inhibitors",
"promoter hypermethylation",
"genetic alterations",
"significant differences",
"HNPCC",
"gastric",
"cancer",
"RASSF1A",
"epigenetic alterations",
"alterations",
"methylation status",
"mutations",
"hypermethylation",
"epigenetic events",
"association studies",
"DNA sequencing",
"malignancy",
"methylation",
"total",
"inhibitors",
"study",
"association",
"status",
"group",
"profile",
"agents",
"setting",
"subset",
"frequency",
"inactivation",
"differences",
"sequencing",
"near future",
"events",
"contrast",
"patterns",
"MSP",
"types",
"implications",
"results",
"possibility",
"future",
"order",
"parameters"
],
"name": "Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer",
"pagination": "7630-7634",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1001626065"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1038/sj.onc.1208906"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"16007118"
]
}
],
"sameAs": [
"https://doi.org/10.1038/sj.onc.1208906",
"https://app.dimensions.ai/details/publication/pub.1001626065"
],
"sdDataset": "articles",
"sdDatePublished": "2022-08-04T16:56",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_410.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1038/sj.onc.1208906"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1208906'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1208906'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1208906'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1208906'
This table displays all metadata directly associated to this object as RDF triples.
293 TRIPLES
21 PREDICATES
123 URIs
108 LITERALS
20 BLANK NODES